BFA
TMO icon

Bragg Financial Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bragg Financial Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.72M Buy
15,397
+749
+5% +$360K 0.21% 118
2026
Q1 		$7.2M Buy
14,648
+586
+4% +$318K 0.23% 125
2025
Q4 		$8.15M Buy
14,062
+303
+2% +$171K 0.27% 112
2025
Q3 		$6.67M Sell
13,759
-178
-1% -$82.9K 0.22% 126
2025
Q2 		$5.65M Buy
13,937
+439
+3% +$184K 0.2% 132
2025
Q1 		$6.72M Buy
13,498
+538
+4% +$291K 0.28% 117
2024
Q4 		$6.74M Buy
12,960
+143
+1% +$78.6K 0.27% 117
2024
Q3 		$7.93M Buy
12,817
+416
+3% +$246K 0.33% 107
2024
Q2 		$6.86M Buy
12,401
+173
+1% +$99.1K 0.31% 109
2024
Q1 		$7.11M Buy
12,228
+380
+3% +$213K 0.32% 108
2023
Q4 		$6.29M Sell
11,848
-1,274
-10% -$617K 0.3% 112
2023
Q3 		$6.64M Buy
13,122
+612
+5% +$326K 0.35% 103
2023
Q2 		$6.53M Buy
12,510
+588
+5% +$317K 0.36% 105
2023
Q1 		$6.87M Buy
11,922
+659
+6% +$371K 0.41% 100
2022
Q4 		$6.2M Buy
11,263
+1,132
+11% +$600K 0.38% 105
2022
Q3 		$5.14M Buy
10,131
+1,013
+11% +$567K 0.35% 109
2022
Q2 		$4.95M Buy
9,118
+1,208
+15% +$665K 0.33% 108
2022
Q1 		$4.67M Buy
7,910
+1,909
+32% +$1.1M 0.27% 116
2021
Q4 		$3.43M Hold
6,001
– – 0.22% 124
2021
Q3 		$3.43M Buy
6,001
+679
+13% +$373K 0.22% 124
2021
Q2 		$2.69M Buy
5,322
+951
+22% +$449K 0.17% 135
2021
Q1 		$2M Buy
4,371
+1,144
+35% +$546K 0.13% 145
2020
Q4 		$1.5M Buy
+3,227
New +$1.51M 0.13% 144

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Bragg Financial Advisors's TMO Position: Q2 2026 in Review

Bragg Financial Advisors increased its Thermo Fisher Scientific (TMO) stake by 5.1% in Q2 2026, buying an estimated $360K and bringing the position to 15,397 shares worth $7.72M. The position accounts for 0.21% of the portfolio, ranked #118.

Bragg Financial Advisors first reported a position in TMO in Q4 2020 and has held it in 23 quarters since. The position peaked at $8.15M in Q4 2025. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Bragg Financial Advisors held 15,397 shares of Thermo Fisher Scientific worth $7.72M as of Q2 2026.
  • Bragg Financial Advisors bought 749 Thermo Fisher Scientific shares in Q2 2026, an estimated $360K.
  • Thermo Fisher Scientific made up 0.21% of Bragg Financial Advisors's portfolio in Q2 2026, its #118 holding.
  • Bragg Financial Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and has held it in 23 quarters since.
  • Bragg Financial Advisors's Thermo Fisher Scientific position peaked at $8.15M in Q4 2025.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Bragg Financial Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.